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VDAC3 is the least known isoform of the mammalian voltage-dependent anion selective 
channels of the outer mitochondrial membrane. It has been recently shown that cysteine 
residues of VDAC3 are found over-oxidized. The VDAC3 cysteine over-oxidation was 
associated with the oxidizing environment and the abundance of reactive oxygen species 
(ROS) in the intermembrane space. In this work, we have examined the role of VDAC3 in 
general pathogenic mechanisms at the basis of mitochondrial dysfunction and involving 
the mitochondrial quality control. Many of the diseases reported here, including cancer 
and viral infections, are often associated with significant changes in the intracellular redox 
state. In this sense, VDAC3 bearing oxidative modifications could become marker of the 
oxidative load in the mitochondria and part of the ROS signaling pathway.
Keywords: vDAC3, mitochondria quality control, cancer, cysteine over-oxidation, aging, mitophagy, mitochondrial 
dysfunction
iNTRODUCTiON
The outer mitochondrial membrane (OMM) is a continuous membrane that separates the cytosol 
from the inside of the organelle. It has long been imagined as a simple envelope, perforated by plenty 
of water-filled holes, as it has recently been illustrated in evocative AFM images (1). Nevertheless, 
the OMM can be considered the border of the mitochondria and any message to be communicated 
outside the mitochondrion has to be dealt with it. Furthermore, the OMM is involved in fusion– 
fission, communicates to the cell about the derangements in the bioenergetics processes, and rules 
the interaction of cytosolic molecules with the mitochondrion: these large or hydrophobic molecules 
require a specific docking structure. Cytoskeletal components (2, 3), ribosomes (4), and enzymes 
(5–8) contact the outer surface of mitochondria, or anchor to it, for structural or organizational 
purposes. The importance of OMM is demonstrated by the catastrophic results of its destruction: 
when the intactness of the OMM is destroyed, in the so-called permeability transition, the apoptotic 
cascade begins (9).
The most abundant protein located in the OMM is the family of pore structures called VDACs 
(for voltage-dependent anion selective channels). They are considered rather unspecific, hollow, 
water-filled pores (10–12): in contrast with Tom40, another pore-forming protein of the OMM, 
with similar structure, is devoted to channeling polypeptides to be folded in mitochondria (13). 
The apparent unspecific function contrasts with many roles, many issues, and many pathologies in 
which VDACs have been involved. Several important advancements derived by casual bumping of 
investigations into VDACs: once for all, the very first sequence, at protein level, of human VDAC1 
was performed on a protein believed to be something else, a component of the immune system (14). 
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There is thus a need for a deeper study of VDACs, addressing 
the more profound functions of this group of protein. In this 
work, we have focused our attention onto the least investigated 
mammalian VDAC isoform, named VDAC3, since it was the last 
one to be discovered (15). We report here a survey of its known 
feature and the information about its role in pathology. In gen-
eral, however, a defective VDAC should not impact on a single 
pathology but instead be part of the mitochondrial dysfunction, 
in turn associated with a myriad of cellular pathological states.
vDAC3 STRUCTURe: THe eSSeNTiAL 
iNFORMATiON
The VDACs are a small family of proteins whose primary role 
is to form an aqueous pore through the OMM that allows the 
exchange of metabolites and molecules (10–12). In chordates, 
and in particular in mammals, three distinct VDAC isoforms 
are coded in the nucleus and targeted to the mitochondria (16). 
The VDAC sequences are conserved, have a length of about 280 
amino acids, and, despite they form a hydrophilic barrel, they 
behave as integral membrane proteins in the isolation procedures, 
comparable to the transmembrane carriers (17, 18).
3D structures of mouse and human VDAC1 isoform have 
been experimentally determined by X-ray crystallography and 
NMR (19–21). Since the sequences are conserved, a similar 
structure has been hypothesized for the other two isoforms (22, 
23). The VDAC2 structure from zebrafish has been solved, and 
it is very similar to the VDAC1 (24). Interestingly, the zebrafish 
VDAC2 has no N-terminal extension typical of this isoform in 
mammalian and has only one cysteine in its sequence (Cys 127). 
The β-strands are arranged in an antiparallel bunch strengthened 
by hydrogen bridges between each couple. Since the number of 
strands is odd, the first and last strands run in parallel: this is a 
peculiarity of mitochondrial VDACs in comparison with bacte-
rial porins, which form an even, completely antiparallel β-barrel 
(25). The β-strands are connected by short turns or loops. As it 
is more evident for the bacterial porins (25), shorter turns crowd 
one side of the barrel [toward the intermembrane space (IMS)], 
and slightly longer loops the other side (the cytosol). The assign-
ment of the turns and loops to a definite side of the membrane 
was a very important achievement (26) because it allows to 
investigate the availability of single amino acid residues to one 
of the two sides of the outer membrane. The last peculiarity of 
the VDAC structure is the N-terminal tail, a sequence of 25–36 
amino acids (36 in VDAC2) predicted to form an exotic α-helix in 
a whole β-strands structure (27). The sequence has been assigned 
by structural determinations inside the pore, with a strong 
tendency to fold as an amphipathic α-helix. However, the exact 
arrangement of this segment requires further refinement, because 
there are slight differences in the available structures (28). The 
importance of the N-terminal tail has been highlighted in many 
works, since its involvement in the dynamic gating of the pore is 
possible.
The VDAC3 structure has not yet been obtained. Several 
bioinformatic predictions have been proposed, based on the large 
sequence similarity, with a β-barrel core almost identical to the 
other VDAC isoforms (23). Unfortunately, very little information 
about this isoform is present in the literature (29).
The puzzling question refers to the presence in the mitochon-
dria of three different isoforms with very similar structure. The 
three VDACs are encoded by distinct genes located on different 
chromosomes (22, 30): they share the same exon–intron organi-
zation indicating that they are the result of not evolutionary far 
duplications (22, 30, 31): but the presence, the different expres-
sion levels (32–34), the different results of each gene K.O. (35–38) 
indicate that during evolution three VDAC genes were fixed in 
the chordate genome, most likely because they improved the cell 
(or the mitochondria) fitness.
ReCeNT iNveSTiGATiONS ON THe 
MAMMAL vDAC3: OveR-OXiDATiON OF 
CYSTeiNeS
Our working hypothesis about a specific function of VDAC3 
begun from the sequence analysis. It is evident that a striking dif-
ference among VDAC isoforms is the number of cysteines in the 
sequences. In human, VDAC1 has two Cys, VDAC2 has nine Cys, 
and VDAC3 has six Cys. Furthermore, it is indeed interesting that 
the three isoforms show different structural localization of their 
sulfur amino acids (Figure 1).
The sideness determination allowed the assignment of the 
cysteine residues position in interstrands loops or turns. It helped 
to speculate about their exposition to the water environment. 
While VDAC1 contains two Cys, located far from each other and 
interacting, respectively, with the water interior of the pore (Cys 
232 in the β-strand 16) and with the hydrophobic, phospholi-
pidic milieu (Cys 127 in the β-strand 8) (19, 39, 40), the other 
two isoforms’ cysteines mostly protrude toward the IMS (16, 26, 
41). In particular, VDAC2 and VDAC3 show conserved cysteine 
residues at positions 36, 65, and 122; in addition, VDAC3 has Cys 
229 exposed to the IMS, while VDAC2 has not only Cys 92 and 
199 exposed to IMS but also Cys 127 in the middle of β-strand 
8 and Cys 216 in the loop between β-strands 14 and 15. At the 
end, in VDAC2 and VDAC3, two cysteines are localized in the 
N-terminus moiety, thus in the water interior but only one of 
them is conserved at the same position in the two isoforms (Cys 
2 in VDAC3 numbering) [the definition of the turns and loops is 
based on the human VDAC1 structure (19), thus it is predictive 
for the other isoforms; numbering follows the VDAC1 sequence, 
for the sake of clarity; please refer to the scheme in Figure 1]. 
Thus, human VDAC2 has more cysteines than VDAC3 but only 
in VDAC3 they look all preferentially exposed to the IMS.
The IMS is one of the oxidizing environments in the cell, 
together with the ER lumen (42). Its oxidizing power is a conse-
quence of the proton unbalance across the inner mitochondrial 
membrane, due to the electron chain oxidation; the glutathione 
redox balance is also in favor of an oxidative potential (43, 44) 
and Complex III and Monoamine Oxidase directly pour reactive 
oxygen species (ROS) in the IMS (45, 46). It has been observed 
that VDACs are the conduit for the diffusion of the superoxide 
anion outside the organelle (47) and of hydroperoxide, produced 
by the dismutation of superoxide anion by SOD. Thus, we 
FiGURe 1 | Multi-alignment of human mammalian voltage-dependent anion selective channel (vDAC) isoforms. The multi-alignment, obtained by the 
Clustal-X software, reports as a pink box the N-terminal sequence of VDAC1, in mauve the sequences forming the 19 β-strands, and in pale green the sequences 
corresponding to cytosol-exposed loops. The non-colored sequences correspond to the intermembrane-exposed turns (intermembrane space, IMS). The strands 
localization refers to the structure reported in Ref. (19), while the assignment of IMS or cytosolic loops follows the paper by Tomasello et al. (26). Cysteine residues of 
VDAC2 and VDAC3 are in red and outlined in yellow, and the red arrows show those cysteine residues protruding in the intermembrane space.
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suspected that the VDAC cysteines exposed to the IMS could be 
a preferential target to discharge the oxidative load of the ROS in 
the compartment. We focused in particular on VDAC3 and, to 
get a molecular evidence of this hypothesis, we performed high 
resolution Mass Spectrometry analysis on VDAC3 derived from 
rat liver mitochondria (41). The results showed that (i) VDAC3 is 
electrophoretically heterogeneous (i.e., it is present with different 
mobility in SDS-PAGE) because the arrangement of oxidized 
cysteine is different in the various bands; (ii) different molecules 
contain different extents, in terms of type and quantity, of oxidized 
cysteine (we like to call them: “redox isomers”); (iii) the oxidation 
states of the cysteine are not random but some of them (Cysteines 
2 and 8) are always found in a reduced (exactly derivatized by 
iodoacetamide) state, others (Cysteines 36, 65, and 229) in differ-
ent oxidation levels (+1, +3, and +5); (iv) the oxidation to sulfinic 
(+3) or sulfonic (+5) acid is biologically irreversible. The only 
known reductase is thioredoxin/sulforedoxin system that targets 
sulfinic cysteine (48, 49), while there are no known enzymes able 
to reverse the sulfonic acid (+5) whose function is unknown 
and possibly related to either modify the protein electrostatic 
equilibrium or target it for degradation.
What can be the meaning of VDAC3 oxidations for the mito-
chondria within the cellular context?
ReLevANCe OF OXiDATiON STATeS OF 
vDAC3 iN PHYSiOPATHOLOGY: iS vDAC3 
A MARKeR OF THe MiTOCHONDRiAL 
QUALiTY CONTROL AND AGiNG?
We have proposed, well before the discovery of over-oxidized 
cysteines, two explanations for the VDAC3 cysteines exceed-
ing in number those present in VDAC1 (22). In the former 
hypothesis, the load of oxidations of VDAC3, whose role in the 
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permeability of the OMM is not preeminent, can be considered 
as a defensive mechanism: the accumulation of damages on an 
apparently unimportant protein may drain the excess ROS. In the 
latter hypothesis, the accumulation of ROS modifications on the 
same protein, in addition to protect other molecules, can change 
the conformation and/or the docking capability of VDAC3 and 
this modification, in turn, signals the ROS load of the single 
mitochondrion to other structures within the cell.
Recently, deletion of cysteines in engineered VDAC3 mol-
ecules (41, 50) suggested that the oxidized state of these residues 
can decrease the VDAC3 pore-conductance activity (41, 50, 51), 
even though the molecular mechanism of such hindrance to the 
conductance is not clear yet. Okazaki et  al. proposed that the 
transient formation of a disulfide bridge inside the pore could 
strongly change the permeability (50). In our hands, we found 
that a different disulfide bridge can form but does not change 
much the permeation available diameter of the pore (41, 52). 
The modifications to the polypeptide chain conformation due to 
the cys oxidation can also affect the electrical charge disposition 
on the protein surface: in VDACs, the surfaces inside the barrel 
or at the mouths of the pore are hydrophilic (53). Furthermore, 
the insertion of negative charges due to sulfinic and sulfonic 
oxidation can provoke electric repulsions inside the chain or 
toward phospholipids, and next modify the conformation of 
the protein. A similar output has been evidenced in Ref. (52), 
where a molecular dynamic simulation has shown that, in case of 
disulfide formation between the closest cysteine residues avail-
able, the pore diameter would not change, while the exposition 
of residues, or of part of the N-terminal moiety, to the extra-
membranous environment would change (52, 54). These confor-
mational changes can be “sensed” in the cell as modification of 
the docking properties of the outer mitochondrial surface. The 
amounts of ROS in each mitochondrion can indeed cause VDAC 
cysteine oxidation proportional to the ROS concentration. We 
thus speculated that the quantitative extent of VDAC oxidative 
modifications on the mitochondrial surface can be used as a 
signal of oxidation load, allowing the monitoring of the ROS 
amounts in each mitochondrion or mitochondrial network 
section (Figure  2). At the end, oxidation of the cysteines in 
VDAC could provoke the binding or the release of yet unknown 
interactors.
VDAC2 is also rich in cysteines: it is possible that this isoform 
could also fulfill a similar function. The differences in number 
and location of cysteine residues do not support an overall over-
lapping of the VDAC2 and VDAC3 functions. Unfortunately, 
the molecular analysis of VDAC2 by mass spectrometry has not 
been completed, thus it is premature to draw conclusions about 
VDAC2.
It is well known that mitochondria are subjected to quality 
control systems that allow the cell to dispose malfunctioning 
organelles or just part of them. Such a quality control has the 
role to avoid that the cell is affected by a relevant mitochondrial 
dysfunction, an event reported in a large number of degenerative 
pathologies. The single affected organelle is targeted to lysosomes 
and destroyed. As an alternative, single proteins, or membrane 
patches are identified as damaged portions of the organelle 
and destroyed by a complex process involving the formation of 
mitochondria-derived vesicles (MDVs) and their targeting to 
lysosomes [reviewed in Ref. (55)].
The production of MDVs is a process stimulated by the 
mitochondrial stress. In a recent work where the MDV pathway 
has been dissected and characterized, it was demonstrated 
that MDVs are enriched in oxidized proteins derived from 
mitochondria and in particular from the outer membrane (56). 
The authors suggested indeed that the protein conformational 
changes subsequent to oxidation can initiate their incorporation 
into MDVs. The oxidized state of proteins was demonstrated with 
immunoblots targeting carbonylated amino acids (56). VDAC1 
was found among the proteins in MDVs. Unfortunately, the 
oxidation state of cysteines was not investigated nor the presence 
of VDAC3 in MDVs.
It is peculiar for VDAC3 that the post-translational modifi-
cation deletes the starting methionine in the sequence, leaving 
N-terminal residue the cysteine encoded as second amino acid 
(Cys 2). Cysteine at the N-terminal position is subjected to the 
so-called “N-end rule pathway,” a destructive process involving 
the oxidation of the N-terminal Cys, its selective arginyla-
tion and, at the end, its ubiquitination (53, 57). This pathway 
forwards the modified protein from the mitochondria through 
a retrotranslocation pathway to the cytosolic proteasome for 
its recycling, similar to the ER-associated degradation pathway 
(ERAD). In our studies, Cys 2 in VDAC3 was never found 
oxidized: the oxidized N-terminal cysteine is the precursor 
stage for the N-end pathway. Cysteine 2 in VDAC3 was instead 
always found involved in a disulfide bridge (41). During the MS 
pre-processing of the samples, Cys 2 was reduced and modified 
with iodoacetoamide. Iodoacetoamide irreversibly modifies the 
reduced cysteines, marking them as reduced or reducible in the 
conditions of analysis. The lack of any evidence of Cys 2 oxidation 
might just mean that each single protein altered in this way in the 
cell is immediately destroyed by the retrotranslocation pathway 
(N-end rule pathway). VDAC3 has been identified as a Parkin 
interactor and subjected to ubiquitination by Parkin in defective 
mitochondria (58). The PINK1/Parkin system is responsible 
for the elimination of defective mitochondria by autophagy 
(59). PINK1 is a kinase present, at very low levels, in the OMM, 
that is able to phosphorylate Parkin upon its recruitment from 
cytosol to the OMM. The phosphorylated Parkin starts ubiqui-
tination of selected targets in the mitochondria and this event 
is considered preliminary to the mitochondrial quality control 
(or to mitophagy). Experiments by Sun et al. support a model in 
which VDACs are part of the machinery that recruits Parkin to 
the organelle (58). By mass spectrometry, VDAC isoforms have 
been found to be the most abundant Parkin-associated proteins, 
indicating their role as mitochondrial docking site for Parkin. 
Interestingly, while VDAC3 was found ubiquitinated, VDAC2 
can bind Parkin but it was not detected ubiquitinated (58). This 
difference can be due to the lack of the N-terminal cysteine in the 
mature form of VDAC2. When the Cys 2 is reduced or forms a 
disulfide bridge (41, 50), the VDAC3 protein can follow the same 
degradation pathway followed by the other isoforms.
During aging, stem cells sustain damages until they become 
exhausted (60). To reduce and slow the accumulation of such dam-
ages, stem cell might segregate ruined subcellular components 
FiGURe 2 | Proposed model of mitochondrial reactive oxygen species (ROS) and vDAC3 cysteine residues interaction. Little amounts of ROS oxidize 
some VDAC3 cysteines that protrude toward the mitochondrial intermembrane space up to sulfinic and sulfonic oxidation states. In addition to a conformational 
change in the protein, such irreversible modifications recruit the PINK/Parkin system that in turn ubiquitinates VDAC3. This step, followed by the proteasome 
degradation of the ubiquitinated protein, is preliminary to the mitochondrial quality control (upper panel). The progressive accumulation of ROS, due to mitochondrial 
stress, increases the amount of oxidized cysteines in VDAC3. This phenomenon stimulates the incorporation of single damaged proteins, or membrane patches 
containing damaged proteins, into mitochondria-derived vesicles, subsequently targeted to lysosomes (middle panel). When the ROS level reaches a maximum 
threshold, almost all VDAC3 proteins of the outer mitochondrial membrane become heavily modified by irreversible oxidations. Conformational changes derived from 
these modifications signal the redox state of the mitochondria to the rest of the cell. Damaged, reactive oxygen species-producing mitochondria are therefore 
removed through mitophagy (lower panel).
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away from the new stem cell. This trick would be extremely 
useful, excluding damaged mitochondria from the new, daughter 
stem cells. Katajisto et al. (61) were able to monitor the fate of 
aged mitochondria by using a photoactivable GFP tag linked to 
an outer membrane protein, the Omp25. The conclusion of this 
study was that apportioning of mitochondria to daughter cells 
from a stem cell is not symmetric: old, aged mitochondria are 
confined to the somatic cell and not to the daughter stem cell (61). 
This interesting work showed that, in stem cell, a modification 
marking old mitochondria must exist, to permit the asymmetric 
apportioning that is useful to stem cells.
Can the over-oxidation of cysteines in VDAC3 be one of the 
markers of such aging? It is not straightforward to imagine that 
the cysteines, exposed to the IMS, can direct a signal on the other 
side of the membrane (cytosol). We hypothesize that the over-
oxidation of cysteines and/or other modification-like formation 
or break of disulfide bridges (41, 50, 54) can modify the structure 
of the pore or the electrostatic properties of the water-exposed 
surfaces and the mobility of the N-terminus. This conformational 
change could be the real switch (see Figure  2 for a cartoon 
depicting this hypothesis). A further protein, whose interaction 
with VDAC3 is modified upon the pore conformational change, 
should thus be hypothesized as an intermediate messenger.
iNTeRACTOMiC ANALYSiS CONFiRMS 
THe ROLe OF vDAC3 iN 
MiTOCHONDRiAL PROTeiN QUALiTY 
CONTROL
The relationship of VDAC3 with cellular systems was highlighted 
in the catalog of proteins found to interact with this isoform 
in  vivo by a TAP-Tag immunoprecipitation strategy and mass 
spectrometry identification (62). Proteins from the endoplasmic 
reticulum were found to be well represented: Grp75, Hsp70, 
GRP, and calreticulin. They are also markers of the MAM, the 
mitochondria-associated membranes, considered as contact 
point and exchange site between mitochondria and ER (63). 
Other crucial pathways were clearly correlated to VDAC3 based 
on the presence of interacting proteins involved in it. Proteins 
correlated to oxidative stress (GSTO-1, PRDX, and GSTK-1), 
proteins involved in the response to misfolded or unfolded 
proteins (YWHAQ, KCIP1, or SFN), proteasomal components 
and chaperons (PDI and Erp5) (64, 65), and proteins related to 
ribosome contact and control, were identified (62).
Isoforms of protein disulfide isomerases, peroxiredoxins, glu-
tathione transferases, involved in maintaining the redox status, or 
glutathione S-transferase kinase 1 (GSTK-1) were among VDAC3 
interactors (66, 67). Mammalian unfolded protein response 
utilizes two main mechanisms able to eliminate misfolded 
proteins: upregulation of chaperons and proteolytic degradation 
by ubiquitin–proteasome and autophagy–lysosome system (68). 
Proteins like the interesting but poorly known 14-3-3 protein 
theta, the protein kinase C-inhibitor, or the stratifin, are compo-
nents of these pathways and were indeed among the interactors. 
Also, the ERAD (69, 70), where the endoplasmic reticulum faces 
accumulation of mis-folded or unfolded proteins, was found well 
represented with proteins like chaperones, oxidases, and thiol-
isomerases (i.e., protein disulfide isomerases, calreticulin) (62).
A very interesting interactor of VDAC3 found in Ref. (62) is VCP 
(TER-ATPase). VCP is a member of the ERAD pathway and is involved 
in the “extraction” of protein from the OMM and other membranes 
to be directed to ubiquitination and degradation through ER, with 
or without stress conditions (64). VCP mutants have been correlated 
to the onset of some type of myopathies, of frontotemporal dementia 
and of Alzheimer disease, Parkinson’s disease, or amyotrophic lateral 
sclerosis, all pathologies where VDAC involvement has been already 
reported (71–74). VCP could be in charge of extracting the modi-
fied version of VDAC3, addressing it toward microtubules through 
cytoplasmic granules’ traffic (62) and enriching near the centrosome. 
VDAC3 has been detected at the centriole and its role in ciliogenesis 
has been proposed (75, 76). To draw a more careful and comparative 
comparison of the VDAC isoforms’ roles, the interactomic analysis of 
VDAC2, presently lacking, would be essential.
vDAC iN PATHOLOGieS
At dawning of VDAC research, when there were only suspects of 
more VDAC isoforms and the human genome sequence was not 
completed, it raised a substantial interest that the claim of VDAC1 
lack in a human patient, suffering of an undiagnosed encephalo-
myopathy (77). The evidence come out from Western blot of the 
skeletal muscle biopsy of a 3-year-old child, suffering of dysmor-
phism, hypotonia, respiration and feeding problems, and seizures. 
The underlying idea was that suspected, but not diagnosed, mito-
chondrial pathologies could be due to the absence of a transport 
protein, located in the mitochondrial membranes. This strategy 
gave raise to a screening with anti-VDAC1 antibodies run on 
muscle mitochondria membranes. About 100 suspected patients 
were investigated for VDAC1 deficiency in the Netherlands and 
Italy (78). As reported in Ref. (71), the patients to be examined 
were selected on a biochemical basis, having to show (a) dimin-
ished substrate oxidation rates not caused by a disturbance in the 
respiratory chain, citric acid cycle, or pyruvate dehydrogenase 
complex or (b) normal activities of the respiratory chain enzymes 
and the pyruvate dehydrogenase complex, together with strong 
suspicion for mitochondrial disorder based on both clinical and 
clinical–chemical hallmarks (79). The search for VDAC deficiency 
at a protein level was nevertheless later abandoned because the 
paucity of putative patients and their spread. In addition, the lack 
of reliable antibodies, working specifically against each singular 
VDAC isoform, hindered the possibility to study different pores. 
Most of the information about VDACs and in particular VDAC3 
involvement in pathologies stemmed, thus, by wide-scale analysis 
of gene expression or general proteomic surveys. In many of them, 
evidence of the presence of altered levels of VDAC isoforms and 
in particular of VDAC3 was often found (80, 81).
eviDeNCe OF vDAC3 iNvOLveMeNT iN 
CANCeR
In a recent survey with the Ingenuity Pathway Analysis software on 
VDAC3 interacting proteins, aimed to discover the pathological 
FiGURe 3 | involvement of vDAC3 in cancer. The anti-tumor agent erastin induces rapid, oxidative, non-apoptotic death in human tumor cells that have 
mutations in the oncogenes HRAS, KRAS, or BRAF. On the outer mitochondrial membrane, erastin binds VDAC2 and VDAC3 but is not able to interact with 
VDAC1. After erastin treatment, VDAC2 and VDAC3 expression is strongly reduced, while VDAC1 is still present at later time points (left panel). Dimeric αβ-tubulin is 
able to inhibit VDAC1 and VDAC2 conductance more than VDAC3 ones. This interaction suppresses mitochondrial respiration and contributes to the establishment 
of the Warburg metabolism in tumor cells. Erastin prevents and reverses tubulin-induced voltage-dependent anion selective channel blockage and promotes 
mitochondrial metabolism (right panel).
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processes underneath this group of proteins, it was noticed that 
the processes with the highest score, by far highest than the 
threshold, were cancer and reproductive system diseases (62).
Evidence for a VDAC3 responsibility in specific mechanisms 
connected to cancer come from studies with erastin. The anti-
tumor agent erastin induces oxidative, non-apoptotic death in 
human tumor cells with mutations in the oncogenes HRAS, KRAS, 
or BRAF. Using affinity-based target identification and MS/MS 
analysis, Yagoda et al. (82) identified VDAC2 and VDAC3 as the 
docking sites for erastin binding to mitochondria. In response to 
oncogenic HRAS, the total amount of VDAC protein is increased 
suggesting that erastin acts by a gain-of-function mechanism 
and that cells with more VDAC protein are more sensitive to 
erastin. Following erastin treatment, however, VDAC3 first 
and subsequently VDAC2 become undetectable. Hence, it is 
possible to hypothesize that a cellular response to erastin is the 
downregulation of VDAC2/3 after the generation of lethal oxida-
tive species (Figure 3). On the contrary, VDAC1 is not altered 
after erastin exposure suggesting that the loss of VDAC2/3 is 
not simply caused by loss of mitochondria. The K.O. of VDAC3 
significantly increases cell resistance to erastin and similar results 
are reported for VDAC2 K.O. In contrast, overexpression of 
VDAC3 alone does not increase sensitivity to erastin, suggesting 
that VDAC3, and partially VDAC2, is necessary but not sufficient 
to raise sensitivity to erastin, and that other downstream features 
of RAS–RAF–MEK signaling are necessary. In 2013, Maldonado 
et al. (83) discovered that erastin prevents and reverses tubulin-
induced VDAC blockage to promote mitochondrial metabolism. 
As already reported, dimeric αβ-tubulin is able to block the con-
ductance of VDAC and suppress mitochondrial respiration (84, 
85). Single and double K.O. of VDAC isoforms in HepG2 cells 
showed that endogenous tubulin inhibits VDAC1 and VDAC2 
conductance more than VDAC3 conductance (86). It has been 
speculated that the interaction between VDAC and tubulin may 
underlie modulation of energy metabolism in proliferating cells. 
During interphase, high free tubulin inhibits VDAC fluxes of 
ATP/ADP and other respiratory substrates across OMM, thereby 
suppressing mitochondrial respiration and promoting aerobic 
glycolysis in order to increase biomass formation. The decrease 
of free tubulin accompanying the cell division, instead, leads to 
the VDAC opening and the activation of oxidative phosphoryla-
tion that in turn generates the energy needed for chromosome 
movement and cytoplasmic division (86). In the light of the above 
results, the interaction between free tubulin and VDAC in cancer 
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cells, which frequently show numerous alterations in the micro-
tubule network (87), possibly contributes to the establishment of 
the Warburg metabolism (86).
vDAC3 iN DiSeASeS DiFFeReNT FROM 
CANCeR
Some reports in the literature show the involvement of VDAC3 
in pathologies and diseases different from cancer. Chronic unpre-
dictable stress (CUS), one of the most clinically relevant stress 
paradigms in rodents, mimics several behavioral characteristics 
of patients affected by depression, anxiety, and mood disorders. 
In a zebrafish model of CUS, Chakravarty et al. identified VDAC3 
as a differentially regulated gene among other proteins involved in 
mitochondrial function (80). The authors hypothesized that the 
increased level of VDAC3 in stressed fish brain might increase the 
efficiency of bioenergetic metabolism and/or protection against 
ROS (80).
Alterations in the expression levels of VDAC3 have also been 
reported in the brain of mice infected by Plasmodium berghei, 
a well-studied mouse model of cerebral malaria (81). Cerebral 
malaria is the most severe neurological complication of infec-
tions by Plasmodium falciparum. This disease, mostly diffused in 
sub-Saharian Africa, has a high mortality and surviving patients 
generally manifest long-term neurocognitive impairment. The 
mechanisms underlying the brain injury are still unclear, and 
the upregulation of vdac3 is accompanied by alterations of many 
other genes whose dysfunction is associated with neurological 
disorders (81).
THe iNTeRACTiONS BeTweeN vDAC3 
AND CYTOSKeLeTAL PROTeiNS ARe THe 
BASiS FOR DiSORGANiZATiON OF 
eNDOCeLLULAR FUNCTiONS?
The term “ciliopathies” refers to a series of genetic disorders 
associated with abnormal formation or function of cilia. The 
ciliopathies cause multisystem pathologies that can manifest 
with a plethora of features including retinal degeneration, cer-
ebral anomalies, skeletal dysplasia, and fibrocystic diseases of the 
liver. It has been reported that VDAC3 is targeted to centrosome 
where it is mainly associated to the mother centriole/basal body 
(75). Here, it recruits Mps1, a protein kinase essential for the 
spindle assembly checkpoint and the modulation of centriole 
assembly in vertebrates. Depletion of VDAC3 cause defects in 
centriole assembly and in cell cycle enter. Further evidences 
revealed that VDAC3 and Mps1 cooperate to promote ciliary 
disassembly, while VDAC3 might have the additional function 
to inhibit cilia assembly in cycling cells (76). Interestingly, an 
earlier study demonstrated that, in VDAC3 K.O. mice, structural 
defects in the microtubular organization of the sperm tail cause 
markedly reduced sperm motility (36). As a consequence, male 
mice lacking VDAC3 are infertile. The molecular relationship 
between this defect and the VDAC deficiency is not known. It 
was found that VDAC3 is transcribed at specifically high levels 
in testis (33). Histochemical staining of bovine testis showed that 
VDAC1 is present in Sertoli cells and VDAC2 (but not VDAC1) 
in spermatocytes (88). By means of isoform-specific antibodies 
and biochemical evidence, it has been found that VDAC2 and 
VDAC3 are abundant in mature spermatozoa and appear to be 
associated with outer dense fibers of the sperm flagellum (89). 
Interestingly, also an association of VDAC isoforms with sper-
matozoa and ovarian tissue organization was found in Drosophila 
melanogaster (90, 91). In contrast, the work by Liu et al. assessed 
that no difference in VDAC3 expression levels exists between 
normozoospermic fertile donors and infertile patients with idi-
opathic asthenozoospermia; they instead found a high expression 
of VDAC2 (92).
It is important to note that human spermatozoa undergo 
extensive redox regulated signaling since nitric oxide (NO) is 
involved in sperm motility, capacitation, acrosome reaction, and 
enhancement of sperm binding to zona pellucida. NO induces 
S-nitrosylation, a post-translational protein modification that 
regulates cellular signaling. VDAC3 was identified as a target of 
S-nitrosylation in spermatozoa (93). Okazaki et  al. found that 
S-nytrosilation activated VDAC3 channel activity by breaking 
S–S bonds (50).
iMPLiCATiONS OF vDAC3 iN viRAL 
iNFeCTiONS
Many viruses encode proteins targeting to mitochondria. These 
proteins are able to modulate apoptosis in infected cells. In 
general, all the anti-apoptotic viral proteins contain mitochon-
drial targeting sequences that are responsible for inserting the 
protein in the OMM. In contrast, pro-apoptotic proteins like the 
HBx antigen from hepatitis B virus (HBV) contain amphipathic 
α-helices. HBV is a small hepatotropic DNA virus responsible 
for acute and chronic liver disease worldwide. The chronic viral 
infection constitutes a risk factor for hepatocellular carcinoma. 
It can indeed not only evolve to cirrhosis but also impact on cell 
cycle regulation and tumor suppressor genes alterations. It was 
reported that in HepG2 and HuH7, two hepatocarcinoma cells 
lines, HBx colocalizes with VDAC3 in the OMM (94, 95) and 
causes alterations in mitochondrial membrane potential (ΔΨm) 
leading to the activation of the transcription factors STAT-3 and 
NF-κB (96). The activation of these factors is sensitive to antioxi-
dants and to the overexpression of Mn-superoxide dismutase II, 
suggesting a potential role of ROS in the pathogenesis of the dis-
ease. The release of cytochrome c in response to the HBx-induced 
mitochondrial membrane potential variation is instead a late 
event, indicating that during the stage of chronic HBV infection, 
HBx expression may sensitize apoptosis in infected hepatocytes, 
generating HBV pathogenesis and favoring propagation of the 
viral particles. Since Bcl-2 family proteins bind to VDAC to 
regulate the release of cytochrome c, it has been proposed that 
VDAC3–HBx interaction might induce conformational changes 
that abolish the modulation of channel activity by Bcl-2. VDAC3 
seems to be involved also in HHV-8 infection, an oncogenic 
human herpes virus that has been identified in all types of Kaposi’s 
sarcoma. Wang et al. (97) reported indeed that HHV-8 K7 protein 
binds to mitochondrial VDAC3.
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CONCLUSiON
In mammals, VDAC3 has been demonstrated to be subjected 
to over-oxidation of its exposed cysteines. The oxidative 
modifications, likely due to the concentration of ROS in the 
IMS, let us propose that it can be candidate to participate in 
the molecular mechanisms of identification of damaged mito-
chondria. Damaged mitochondria characterize the mitochon-
drial dysfunction, a state of the organelle where the oxidative 
phosphorylation is not able to produce enough ATP and ROS 
accumulation is a hallmark. This state must be signaled as soon 
as possible, to remove the damaged organelle. The VDAC3 
cysteine oxidations, which were experimentally proved (41), 
produce changes of the protein electrostatic map, and conse-
quently changes in its presentation to the other compartments. 
The peculiar modifications of cysteines thus make VDAC3 a 
potential counter of ROS load in the IMS. The quest for a mes-
senger able to specifically interact with the oxidized VDAC3 and 
transfer the message to proper responding apparatus will be the 
next step of this story.
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